U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197788) titled 'Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study' on Sept. 26.
Brief Summary: This study is designed to collect real-world data on the safety and performance of the Endogenex System in the cohort of participants who were originally randomized to the sham control arm of the ReCET Study.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes Mellitus
Type2diabetes
Diabetes Mellitus, Type 2
Type 2 Diabetes
Diabetes
Intervention:
DEVICE: Endogenex System
The Endogenex System procedure utilizes a catheter to deliver non-thermal pulsed electric field to the first port...